Precision BioSciences, Inc. (DTIL) vs Humacyte, Inc. (HUMA)
Precision BioSciences, Inc. and Humacyte, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and Humacyte, Inc. are of similar size ($174.7M and $166.7M). Humacyte, Inc. grew revenue faster over the last twelve months: 149.8% against −11.9%. Precision BioSciences, Inc. has the higher net margin (0.00% vs −4,448.9%) and the higher return on invested capital (0.00% vs −433.7%). Across the 17 metrics below, Precision BioSciences, Inc. leads on 14 and Humacyte, Inc. on 3.
Valuation
Profitability
| Metric | DTIL | HUMA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | (494.58%) | 65.16% |
| Operating margin | 0.00% | (5,240.78%) | 0.00% |
| Net margin | 0.00% | (4,448.89%) | 0.00% |
| Free cash flow margin | 0.00% | (4,599.72%) | 0.00% |
| Return on equity | (132.91%) | (534.42%) | (57.72%) |
| Return on assets | (44.91%) | (68.16%) | (49.22%) |
| Return on invested capital | 0.00% | (433.66%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack